Literature DB >> 21324695

Tumor size and survival in multicentric and multifocal breast cancer.

Angela Rezo1, Jane Dahlstrom, Bruce Shadbolt, Karl Rodins, Yanping Zhang, Alison J Davis.   

Abstract

PURPOSE: Current AJCC/UICC staging of early breast cancer defines tumor stage using the largest focus, adding the suffix "(m)" to indicate multiplicity. This method may underestimate the total tumor burden in multifocal and multicentric breast cancer (MMBC). This study examines other measures of tumor size in MMBC to determine which provides the best fit in a multivariate model for survival outcomes. PATIENTS AND METHODS: This prospective cohort study used data from the Australian Capital Territory and New South Wales Breast Cancer Treatment Group database to identify 812 women with ipsilateral invasive breast cancer; 141 of these women had MMBC. The pathology slides of all women with MMBC were reviewed and all foci of invasive breast cancer were re-measured. The measures of interest were the diameter of the largest deposit, the aggregate diameter and the aggregate volume. These measures of tumor size were included with other clinicopathological features of MMBC in a multivariate analysis to assess their relationship with progression-free survival (PFS) and overall survival (OS).
RESULTS: Tumor size was associated with PFS and OS in MMBC using any of the three measures; however, the diameter of the largest deposit provided the best fit in the multivariate model for OS.
CONCLUSION: Tumor size is an important prognostic factor for MMBC, and the diameter of the largest deposit provides a better fit in a multivariate model for OS than aggregate diameter and aggregate volume. Therefore, tumor size in MMBC should continue to be measured using the diameter of the largest deposit.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21324695     DOI: 10.1016/j.breast.2011.01.005

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  13 in total

1.  Prognostic impact of multifocal and multicentric breast cancer versus unifocal breast cancer.

Authors:  Atsushi Fushimi; Atsushi Yoshida; Hiroshi Yagata; Osamu Takahashi; Naoki Hayashi; Koyu Suzuki; Hiroko Tsunoda; Seigo Nakamura; Hideko Yamauchi
Journal:  Surg Today       Date:  2018-10-13       Impact factor: 2.549

Review 2.  Is breast conservative surgery a reasonable option in multifocal or multicentric tumors?

Authors:  Gilles Houvenaeghel; Agnès Tallet; Aurélie Jalaguier-Coudray; Monique Cohen; Marie Bannier; Camille Jauffret-Fara; Eric Lambaudie
Journal:  World J Clin Oncol       Date:  2016-04-10

3.  Personal history of proliferative breast disease with atypia and risk of multifocal breast cancer.

Authors:  Ellen L Nutter; Julia E Weiss; Jonathan D Marotti; Richard J Barth; M Scottie Eliassen; Martha E Goodrich; Curtis L Petersen; Tracy Onega
Journal:  Cancer       Date:  2017-12-20       Impact factor: 6.860

4.  Clinical implications of multifocality as a prognostic factor in breast carcinoma - a multivariate analysis study comprising 460 cases.

Authors:  Monica Boros; Septimiu Voidazan; Cosmin Moldovan; Rares Georgescu; Cornelia Toganel; Denisa Moncea; Claudiu V Molnar; Cristian Podoleanu; Alexandru Eniu; Simona Stolnicu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

5.  Comparison of the histopathology and prognosis of bilateral versus unilateral multifocal multicentric breast cancers.

Authors:  Hüseyin Kadioğlu; Serdar Özbaş; Alper Akcan; Aykut Soyder; Lutfi Soylu; Savaş Koçak; N Zafer Cantürk; Mustafa Tükenmez; Mahmut Müslümanoğlu
Journal:  World J Surg Oncol       Date:  2014-08-20       Impact factor: 2.754

6.  Introduction of a New Staging System of Breast Cancer for Radiologists: An Emphasis on the Prognostic Stage.

Authors:  Jieun Koh; Min Jung Kim
Journal:  Korean J Radiol       Date:  2018-12-27       Impact factor: 3.500

7.  The Usefulness of Spectral Mammography in Surgical Planning of Breast Cancer Treatment-Analysis of 999 Patients with Primary Operable Breast Cancer.

Authors:  Andrzej Lorek; Katarzyna Steinhof-Radwańska; Anna Barczyk-Gutkowska; Wojciech Zarębski; Piotr Paleń; Karol Szyluk; Joanna Lorek; Anna Grażyńska; Paweł Niemiec; Iwona Gisterek
Journal:  Curr Oncol       Date:  2021-07-12       Impact factor: 3.677

8.  Clinical and pathologic features of multifocal and multicentric breast cancer in chinese women: a retrospective cohort study.

Authors:  Mei-Rong Zhou; Zhong-Hua Tang; Jing Li; Jin-Hu Fan; Yi Pang; Hong-Jian Yang; Shan Zheng; Jing-Qiao Bai; Ning Lv; You-Lin Qiao; Hai-Zhi Qi; Feng Xu
Journal:  J Breast Cancer       Date:  2013-03-31       Impact factor: 3.588

9.  Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors.

Authors:  Nadine Norton; Pooja P Advani; Daniel J Serie; Xochiquetzal J Geiger; Brian M Necela; Bianca C Axenfeld; Jennifer M Kachergus; Ryan W Feathers; Jennifer M Carr; Julia E Crook; Alvaro Moreno-Aspitia; Panos Z Anastasiadis; Edith A Perez; E Aubrey Thompson
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

10.  The Prognostic Impact of Synchronous Ipsilateral Multiple Breast Cancer: Survival Outcomes according to the Eighth American Joint Committee on Cancer Staging and Molecular Subtype.

Authors:  Jinah Chu; Hyunsik Bae; Youjeong Seo; Soo Youn Cho; Seok-Hyung Kim; Eun Yoon Cho
Journal:  J Pathol Transl Med       Date:  2018-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.